Myocardial reperfusion is a pivotal component of cardiovascular care, encompassing the reinstatement of blood flow to the heart muscle following a period of ischemia. Ischemia arises when the blood supply to the heart is temporarily diminished or obstructed, often in the context of a myocardial infarction (heart attack). The primary goal of reperfusion is to alleviate ischemic conditions and mitigate damage to the cardiac tissue. Nonetheless, the restoration of blood flow during reperfusion is a double-edged sword. The abrupt reintroduction of oxygen to the ischemic tissue can trigger oxidative stress and inflammation, contributing to additional injury. Striking a balance between the benefits of reperfusion and the potential harm it may cause is a central challenge in managing cardiovascular diseases.
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : Precision nutrition for heart health: A personalized approach to cardiovascular disease prevention and management
Teji Dhami, BOOST your Health and Wellness, United States